Quanticate

SEPTEMBER 13, 2024

In our article, we cover the key trends that have been shaping clinical trials so far in 2024, and those that are predicted to continue into 2025.

Clinical Trials 95

Clinical Trials Trials Drug Development Treatment 95

Perficient: Drug Development

JANUARY 30, 2025

Our six Sitecore MVP certifications are a testament to our dedication, teamwork, and relentless pursuit of innovation. Here’s to many more milestones and continued success!

Production 59

Production Marketing 59

New Drug Approvals

APRIL 2, 2025

1] [2] It was developed by Vertex Pharmaceuticals , [5] and was approved for medical use in the United States in January 2025. [2] 2] [6] Suzetrigine is the first medication to be approved by the US Food and Drug Administration (FDA) in this new class of pain management medicines. [2] 6 February 2025. 6 February 2025.

FDA 62

FDA Therapies Trials Treatment 62

H1 Blog

OCTOBER 30, 2023

The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. By 2025, we can anticipate pretty significant shifts as AI continues to advance and integrate into various processes within the healthcare ecosystem.

Science 59

Science Clinical Trials Trials Engineering 59

Alta Sciences

APRIL 1, 2025

Insights Care: Altasciences Revolutionizing Early-Phase Drug Development aasimakopoulos Wed, 04/02/2025 - 00:53 Category News Weight 11

Drug Development 40

Drug Development Drugs 40

H1 Blog

DECEMBER 11, 2024

In this edition, our CEO and co-founder, Ariel Katz, along with Regional VP of Trial Landscape, Ryan Brown, share their top predictions for 2025. Drug Policy There will be significant changes in clinical trials & drug development due to the Inflation Reduction Act.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

Alta Sciences

JANUARY 14, 2025

Comprehensive CNS Drug Development Services tchichekian Tue, 01/14/2025 - 15:32 Image FACT SHEET (1).png png Weight 10

Drug Development 40

Drug Development Drugs 40

Alta Sciences

MARCH 4, 2025

Forging a Path Forward for Substance Abuse Potential Studies With the Cross-Company Abuse Liability Council By Beatrice Setnik, PhD pmjackson Tue, 03/04/2025 - 20:10 Many of my colleagues and I are members of the Cross-Company Abuse Liability Council (CCALC), where I have been a co-chair for the past seven years, and a member for 15.

Clinical Trials 52

Clinical Trials FDA Drug Development Trials 52

Alta Sciences

JANUARY 8, 2025

End-to-End CNS Drug Development Solutions tchichekian Wed, 01/08/2025 - 19:22 Image 700X175 CNS LP TOP BANNER IMAGE.png Weight 10

Drug Development 40

Drug Development Drugs 40

Perficient: Drug Development

DECEMBER 12, 2024

Welcome to 2025, where Salesforces Einstein GPT is transforming CRM as we know it. Whats New in 2025? Heres what makes it even better in 2025: Deeper Integrations : Einstein GPT now works seamlessly across all Salesforce CloudsSales, Marketing, Service, and more. Your CRM didnt just sit thereit worked while you slept.

Marketing 52

Marketing Production 52

Perficient: Drug Development

MARCH 17, 2025

Built to maximize modern , cloud-based architecture powered by Databricks, this robust interface equips clinical operations teams to rapidly review, analyze, and discuss all the data for clinical trials, driving faster drug development through heightened collaboration and decision-making.

Clinical Trials 52

Clinical Trials Engineering Trials Science 52

Plenge Gen

JANUARY 7, 2025

My message was that AI-enabled drug discovery was comingsomeday. Fast forward to 2025, and that someday is now. Weve seen an explosion in the availability and capability of AI tools. Just 10 months after I wrote about the theoretical possibilities of AI in biopharma, OpenAI debuted ChatGPT.

Drugs 52

Drugs Production Research Drug Development 52

Fierce BioTech

MARCH 5, 2025

On Demand Start Date Tue, 04/22/2025 - 12:00 End Date/Time Tue, 04/22/2025 - 12:00 Listing Image Cytiva 250x190.png png Listing Introduction While digital transformation is the way of the future, knowing where and how to start your organizations journey toward digital evolution can be challenging.

Drug Development 52

Drug Development Drugs 52

Drug Target Review

JANUARY 8, 2024

We are at the forefront of drug development in an area of research called cellular rejuvenation, which is an approach that has the potential to address many diseases of ageing by restoring aged and injured cells to a more youthful and resilient state.

Science 145

Science Disease FDA Approval Clinical Trials 145

Fierce BioTech

JANUARY 15, 2025

Join us to learn how this technological convergence is reshaping the landscape of drug development and precision medicine. This powerful combination is providing the scientific community with unprecedented capabilities to tackle biological complexity and improve our understanding of the mechanisms underlying cancer development.

Drug Development 52

Drug Development Treatment Research Drugs 52

Fierce BioTech

SEPTEMBER 30, 2024

Fierce Biotech Week Fierce Biotech Week features insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, and navigate capital raising and partnering deals.

Pharma Companies 52

Pharma Companies Drug Development Marketing Drugs 52

Alta Sciences

FEBRUARY 10, 2025

Let Us Guide You Through the Process blussier Mon, 02/10/2025 - 17:54 HTML Let Us Guide You Through the Process Altasciences' experts streamline the IND/CTA application process by designing your regulatory strategy and thoroughly planning and completing your required preclinical studies.

Small Molecule 52

Small Molecule Clinical Trials Drug Development Trials 52

Alta Sciences

JANUARY 31, 2025

Getting to the Heart of Science With Mlanie Constant blussier Fri, 01/31/2025 - 16:53 HTML The Stories That Inspire Meet Mlanie Constant, Manager of Microsoft Solutions. Her story is one of perseverance and is a reminder to us all of the important role of drug development.

Science 52

Science Drug Development Drugs 52

FDA Law Blog: Drug Discovery

MARCH 3, 2025

The American Conference Institutes 3rd Annual Forum on Advanced Therapeutics is scheduled to take place from March 19-20, 2025, at the Seaport Hotel in Boston, MA.

Compliance 52

Compliance FDA Marketing Therapies 52

Fierce BioTech

JANUARY 3, 2025

Optimizing Formulation Strategies for Poorly Soluble Compounds: Insights into Bioavailability Enhancement and Accelerated Development dwunderlin Fri, 01/03/2025 - 15:54 Wed, 02/19/2025 - 11:00 Resource Type Webinar Feng Zhang, Ph.D. On Demand Start Date Wed, 02/19/2025 - 12:00 Hong Li, Ph.D.

Small Molecule 52

Small Molecule Drug Development Drugs 52

PPD

NOVEMBER 30, 2023

As we approach the end of 2023, it’s time to reflect on the past 12 months and how advances in drug development shaped the pharma and biotech industries. Five Predictions for the Drug Development Industry in 2024 1. Stakeholders across the drug development sphere will unlock the transformative potential of AI.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

ACTO

DECEMBER 17, 2024

A survey of healthcare and life science companies found that 93% of these companies expect to increase their spend in 2025. Such cross-functional collaboration ensures consistent implementation from drug development through commercialization. The stakes for AI adoption in the pharmaceutical industry have never been higher.

Government 52

Government Compliance Pharmaceutical Companies Pharmaceuticals 52

Fierce BioTech

DECEMBER 23, 2024

First-in-Human, Drug-Drug Interaction, Food Effect, Bioequivalence, etc.), and often require consistent batches of drug product be administered to groups of research participants within a short timeframe, early phase studies present unique challenges for drug developers not typically experienced in later stages of development.

Pharmacy 52

Pharmacy Trials Clinical Trials Clinical Development 52

Perficient: Drug Development

MARCH 3, 2025

Attending Adobe Summit 2025? We have to start by connecting the dotsand the peoplebehind the content, unlocking the full potential of the organization to scale up content production. Stay tuned for more insights as I prepare for March, and let me know your thoughts on streamlining content workflows in the comments!

Production 52

Production Marketing 52

Perficient: Drug Development

FEBRUARY 27, 2025

Today , we are thrilled to announce Digi-Bridge and Asociacin de Bancos de Alimentos de Colombia (ABACO ) as the next two global organizations selected to receive a $5,00 0 donation from Perficient in the first half of 2025. It comes at a great moment because many families are currently displaced in Colom bia.-

Engineering 52

Engineering Science Research 52

Codon

SEPTEMBER 29, 2024

2025 While the broader life sciences community had pivoted towards working on traditional mechanistic interpretations of biology, one graduate student still believed there was something to be learned using the models of life so celebrated previously. The 2025 genetic network paper fit that bill exactly.

Engineering 140

Engineering Virus DNA Therapies 140

The Pharma Data

DECEMBER 14, 2020

15, 2020 /PRNewswire/ — Gmax Biopharm today holds ground-breaking ceremony for its Zhengzhou, China manufacturing site which is the production base for its GMA102 (T2D), GMA105 (obesity), and GMA301A/B (PAH for adult and children) drugs to be launched between 2023-2025, upon approval of respective clinical trials.

Clinical Trials 52

Clinical Trials Trials Production Drug Development 52

Perficient: Drug Development

FEBRUARY 27, 2025

Actions to start in 2025 Its never too late to gain ground on competitive brands, and particularly brands with no foothold with these two consumer groups. This also is true of consumers with disabilities who tend to be loyal to accessible brands.

Compliance 52

Compliance Research Marketing Production 52

The Premier Consulting Blog

AUGUST 8, 2024

On July 31, 2024, the US Food and Drug Administration (FDA) announced Fiscal Year 2025 (FY2025) Prescription Drug User Fee Amendments of 2022 (PDUFA VII) fee rates for the review of human drug and biological product applications along with prescription drug program fees. i] United States Federal Register.

Drugs 52

Drugs Pharmacokinetics FDA Production 52

Drug Target Review

SEPTEMBER 19, 2024

Could you give us an overview of IRLAB’s current drug development pipeline? Top-line data from the Phase IIb study is expected at the beginning of 2025. The third project in clinical phase, IRL757, is in Phase I and is being developed for the treatment of apathy.

Disease 52

Disease Drugs Treatment Drug Development 52

PPD

JULY 20, 2023

1, 2025, all plastic packaging and manufacturing materials for pharmaceutical use must meet the updated USP <661.2> It also enables drug developers to establish a robust testing history, or source and qualify alternative options should their current packaging systems fail to meet the requirements prescribed in the new chapters.

Packaging 52

Packaging Laboratories Pharmaceutical Companies Compliance 52

Drug Target Review

NOVEMBER 29, 2023

Given the fact that the typical company can spend 10 or more years to progress from identifying a new target to generating human data on a lead therapy, this pace change could transform the future of drug development as we know it. What sort of techniques do you use to analyse genomic data and identify novel drug targets?

Therapies 102

Therapies Disease RNA Engineering 102

Alta Sciences

JANUARY 31, 2025

Guest Blog: Reflecting on the 2024 Society of Toxicology of Canada Symposium, by Ria Falvo, Director, Reporting pmjackson Fri, 01/31/2025 - 15:47 Ria Falvo, Director of Reporting, and Rina Massarelli, Associate Director of Safety Reporting, in Toronto, Ontario, for the 2024 STC Symposium.

Cell Biology 52

Cell Biology Pharmaceutical Companies Clinical Research Government 52

LifeSciVC

JANUARY 16, 2024

Whether trial design, execution, or otherwise, drug development even where there is precedent is a challenging road and should not be taken for granted. Cheers to all the innovative medicines we will collectively shepherd through discovery and development in 2024, and can’t wait to discuss at JPM in 2025!

Small Molecule 140

Small Molecule Trials Therapies Disease 140

Conversations in Drug Development Trends

MAY 23, 2024

The Critical EU-CTR Transition Deadline The three-year transition period for clinical trials authorized under the CTD that are expected to continue beyond the critical deadline of 30 January 2025 are required to transition to the new EU-CTR via a transition application through the CTIS.

Trials 52

Trials Clinical Trials Therapies Treatment 52

Perficient: Drug Development

FEBRUARY 2, 2024

Moving forward, these institutions will need to submit their resolution plans by March 31, 2025. In discussions with financial services executives, Perficient consultants consistently explore the extension of the submission deadline for resolution plans among certain large financial institutions with assets exceeding $250 billion.

Compliance 52

Compliance 52

Perficient: Drug Development

OCTOBER 25, 2023

Enforcement is coming soon from governments around the world by 2025 that global organizations must comply with or pay heavy fines, so it is strongly advised that organizations find experienced partners to improve accessibility as soon as possible.

Engineering 52

Engineering Government Production 52